• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶血磷脂酸(LPA)诱导血管内皮生长因子(VEGF)的表达,从而对B细胞来源的恶性肿瘤细胞凋亡起到保护作用。

Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies.

作者信息

Hu Xiaojie, Mendoza Francisco J, Sun Jinmie, Banerji Versha, Johnston James B, Gibson Spencer B

机构信息

Manitoba Institute of Cell Biology, Winnipeg, MB, Canada.

出版信息

Cell Signal. 2008 Jun;20(6):1198-208. doi: 10.1016/j.cellsig.2008.02.009. Epub 2008 Feb 19.

DOI:10.1016/j.cellsig.2008.02.009
PMID:18396013
Abstract

Vascular endothelial growth factor (VEGF) is a survival and angiogenesis factor that is a target for therapy in a variety of cancers. In many hematological malignancies, VEGF production is increased leading to cell survival responses. Herein, we demonstrate that lysophosphatidic acid (LPA) induces mRNA expression of VEGF in the multiple myeloma cell line, U266, the Burkitt's lymphoma cell line, BJAB, and the chronic lymphocytic leukemia (CLL)-like cell line, I-83. This increase in mRNA levels of VEGF corresponded with increased luciferase activity of the VEGF promoter in BJAB and I-83 cells and increased protein levels in I-83 cells. Secretion of VEGF was also increased in these cells following LPA treatment. LPA treatment also caused the activation of both VEGFR1 and VEGFR2. The increase in VEGF expression by LPA is mediated by the activation of c-Jun N-terminal Kinase (JNK) and transcription factor NFkappaB since blocking JNK or NFkappaB activation inhibited LPA induced VEGF expression. Furthermore, we have demonstrated that LPA protects cells from apoptosis and blocking activation of both VEGFR1 and VEGFR2 using a VEGF receptor kinase inhibitor prevented LPA survival responses. Knocking down expression of VEGFR1 and inhibiting activation of NFkappaB and JNK also blocked LPA induced protection against apoptosis. Taken together, this indicates that LPA contributes to VEGF production in B cell malignancies leading to cell survival.

摘要

血管内皮生长因子(VEGF)是一种生存和血管生成因子,是多种癌症治疗的靶点。在许多血液系统恶性肿瘤中,VEGF的产生增加,导致细胞存活反应。在此,我们证明溶血磷脂酸(LPA)可诱导多发性骨髓瘤细胞系U266、伯基特淋巴瘤细胞系BJAB和慢性淋巴细胞白血病(CLL)样细胞系I-83中VEGF的mRNA表达。BJAB和I-83细胞中VEGF mRNA水平的这种增加与VEGF启动子的荧光素酶活性增加以及I-83细胞中蛋白质水平增加相对应。LPA处理后,这些细胞中VEGF的分泌也增加。LPA处理还导致VEGFR1和VEGFR2的激活。LPA诱导的VEGF表达增加是由c-Jun氨基末端激酶(JNK)和转录因子NFκB的激活介导的,因为阻断JNK或NFκB激活可抑制LPA诱导的VEGF表达。此外,我们证明LPA可保护细胞免于凋亡,使用VEGF受体激酶抑制剂阻断VEGFR1和VEGFR2的激活可阻止LPA的存活反应。敲低VEGFR1的表达并抑制NFκB和JNK的激活也可阻断LPA诱导的抗凋亡作用。综上所述,这表明LPA在B细胞恶性肿瘤中促进VEGF的产生,从而导致细胞存活。

相似文献

1
Lysophosphatidic acid (LPA) induces the expression of VEGF leading to protection against apoptosis in B-cell derived malignancies.溶血磷脂酸(LPA)诱导血管内皮生长因子(VEGF)的表达,从而对B细胞来源的恶性肿瘤细胞凋亡起到保护作用。
Cell Signal. 2008 Jun;20(6):1198-208. doi: 10.1016/j.cellsig.2008.02.009. Epub 2008 Feb 19.
2
Lysophosphatidic acid receptor expression in chronic lymphocytic leukemia leads to cell survival mediated though vascular endothelial growth factor expression.溶血磷脂酸受体在慢性淋巴细胞白血病中的表达导致细胞存活,这种存活是通过血管内皮生长因子的表达来介导的。
Leuk Lymphoma. 2009 Dec;50(12):2038-48. doi: 10.3109/10428190903275586.
3
Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia cells from apoptosis through LPA receptor activation of the anti-apoptotic protein AKT/PKB.溶血磷脂酸(LPA)通过抗凋亡蛋白AKT/PKB的LPA受体激活作用,保护原发性慢性淋巴细胞白血病细胞免于凋亡。
J Biol Chem. 2005 Mar 11;280(10):9498-508. doi: 10.1074/jbc.M410455200. Epub 2004 Dec 23.
4
Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells.p38丝裂原活化蛋白激酶和JNK对溶血磷脂酸诱导人支气管上皮细胞白细胞介素-8表达及分泌的转录调控
Biochem J. 2006 Feb 1;393(Pt 3):657-68. doi: 10.1042/BJ20050791.
5
Lysophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA(1/3), COX-2, and NF-kappaB activation- and EGFR transactivation-dependent mechanisms.溶血磷脂酸通过LPA(1/3)、COX-2和NF-κB激活以及EGFR反式激活依赖性机制上调人内皮细胞中的血管内皮生长因子C并促进其管腔形成。
Cell Signal. 2008 Oct;20(10):1804-14. doi: 10.1016/j.cellsig.2008.06.008. Epub 2008 Jun 21.
6
The NF-κB pathway mediates lysophosphatidic acid (LPA)-induced VEGF signaling and cell invasion in epithelial ovarian cancer (EOC).NF-κB 通路介导溶血磷脂酸(LPA)诱导的上皮性卵巢癌(EOC)中 VEGF 信号和细胞侵袭。
Gynecol Oncol. 2011 Oct;123(1):129-37. doi: 10.1016/j.ygyno.2011.06.006. Epub 2011 Jul 22.
7
Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.溶血磷脂酸诱导血管内皮生长因子表达需要缺氧诱导因子-1α的激活。
Clin Cancer Res. 2006 Nov 1;12(21):6351-8. doi: 10.1158/1078-0432.CCR-06-1252.
8
Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells.葫芦素 I(JSI-124)在 B 白血病细胞中通过非凋亡和细胞周期阻滞激活 JNK/c-Jun 信号通路。
BMC Cancer. 2011 Jun 24;11:268. doi: 10.1186/1471-2407-11-268.
9
Lysophosphatidic acid (LPA)-induced vascular endothelial growth factor (VEGF) by mesothelial cells and quantification of host-derived VEGF in malignant ascites.间皮细胞通过溶血磷脂酸(LPA)诱导血管内皮生长因子(VEGF)以及恶性腹水中宿主来源VEGF的定量分析。
J Surg Res. 2006 Jan;130(1):94-101. doi: 10.1016/j.jss.2005.08.007. Epub 2005 Sep 19.
10
Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression.溶血磷脂酸通过调节Gi/核因子-κB依赖性血管生成因子的表达来增强人软骨细胞的血管生成能力。
PLoS One. 2014 May 30;9(5):e95180. doi: 10.1371/journal.pone.0095180. eCollection 2014.

引用本文的文献

1
Targeting lysophosphatidic acid receptor with Ki16425 impedes T cell lymphoma progression through apoptosis induction, glycolysis inhibition, and activation of antitumor immune response.用Ki16425靶向溶血磷脂酸受体可通过诱导凋亡、抑制糖酵解和激活抗肿瘤免疫反应来阻碍T细胞淋巴瘤的进展。
Apoptosis. 2022 Jun;27(5-6):382-400. doi: 10.1007/s10495-022-01723-2. Epub 2022 Apr 2.
2
Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer.肝癌中溶血磷脂酸代谢与信号传导的失调
Cancers (Basel). 2019 Oct 23;11(11):1626. doi: 10.3390/cancers11111626.
3
Bioactive Phospholipids Enhance Migration and Adhesion of Human Leukemic Cells by Inhibiting Heme Oxygenase 1 (HO-1) and Inducible Nitric Oxygenase Synthase (iNOS) in a p38 MAPK-Dependent Manner.
生物活性磷脂通过抑制血红素加氧酶 1(HO-1)和诱导型一氧化氮合酶(iNOS),以依赖 p38 MAPK 的方式增强人白血病细胞的迁移和黏附。
Stem Cell Rev Rep. 2019 Feb;15(1):139-154. doi: 10.1007/s12015-018-9853-6.
4
A unique role for galectin-9 in angiogenesis and inflammatory arthritis.半乳糖凝集素-9 在血管生成和炎症性关节炎中的独特作用。
Arthritis Res Ther. 2018 Feb 12;20(1):31. doi: 10.1186/s13075-018-1519-x.
5
The role of G protein-coupled receptors in lymphoid malignancies.G 蛋白偶联受体在淋巴恶性肿瘤中的作用。
Cell Signal. 2017 Nov;39:95-107. doi: 10.1016/j.cellsig.2017.08.002. Epub 2017 Aug 9.
6
Cucurbitacin-I (JSI-124) activates the JNK/c-Jun signaling pathway independent of apoptosis and cell cycle arrest in B leukemic cells.葫芦素 I(JSI-124)在 B 白血病细胞中通过非凋亡和细胞周期阻滞激活 JNK/c-Jun 信号通路。
BMC Cancer. 2011 Jun 24;11:268. doi: 10.1186/1471-2407-11-268.
7
Lysophosphatidic acid suppresses endothelial cell CD36 expression and promotes angiogenesis via a PKD-1-dependent signaling pathway.溶血磷脂酸通过蛋白激酶 D1(PKD-1)依赖性信号通路抑制内皮细胞 CD36 的表达并促进血管生成。
Blood. 2011 Jun 2;117(22):6036-45. doi: 10.1182/blood-2010-12-326017. Epub 2011 Mar 25.
8
Epigenetic regulation of WNT signaling in chronic lymphocytic leukemia.慢性淋巴细胞白血病中WNT信号通路的表观遗传调控
Epigenomics. 2010 Feb 1;2(1):53-70. doi: 10.2217/epi.09.43.
9
Lysophosphatidic acid in vascular development and disease.溶血磷脂酸在血管发育与疾病中的作用
IUBMB Life. 2009 Aug;61(8):791-9. doi: 10.1002/iub.220.
10
Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism.Sp-1和c-Myc通过一种不依赖缺氧诱导因子-1的机制介导溶血磷脂酸诱导的卵巢癌细胞中血管内皮生长因子的表达。
Clin Cancer Res. 2009 Jan 15;15(2):492-501. doi: 10.1158/1078-0432.CCR-08-1945.